Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Stefano Persiani"'
Autor:
Gianfranco Caselli, Albino Bonazzi, Marco Lanza, Flora Ferrari, Daniele Maggioni, Cristian Ferioli, Roberto Giambelli, Eleonora Comi, Silvia Zerbi, Marco Perrella, Ornella Letari, Elena Di Luccio, Milena Colovic, Stefano Persiani, Tiziano Zanelli, Laura Mennuni, Tiziana Piepoli, Lucio Claudio Rovati
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-19 (2018)
Abstract Background Prostaglandin E2 (PGE2) acts via its EP4 receptor as a cytokine amplifier (e.g., interleukin [IL]-6) and induces the differentiation and expansion of inflammatory T-helper (Th) lymphocytes. These mechanisms play a key role in the
Externí odkaz:
https://doaj.org/article/22fc8ca4e2234150b60717587ab81196
Autor:
Tiziana Piepoli, Chiara Galimberti, Silvia Zerbi, Gianfranco Caselli, Roberto Artusi, Ornella Letari, Giuseppe M. Montagna, Milena Colovic, Stefano Persiani, Lucio C. Rovati
Publikováno v:
Cancer Research. 80:4219-4219
BACKGROUND: Currently there is no cure for glioblastoma (GBM), the most malignant primary brain cancer. Glioblastoma etiopathogenesis involves mutations and alterations of key signaling pathways including tyrosine kinases (TKs). Notably, aberrant act
Autor:
Lucio C. Rovati, C. Benvenuti, Monique Zangarini, G. Giacovelli, Federica Sala, Stefano Persiani, Milena Colovic, Beatrice Barbetta, C. Manzotti, Cristina Vitalini, Y. Donazzolo
Publikováno v:
Drug Research. 66:136-140
Background: Post-menopausal women under treatment with levothyroxine for their medical conditions may take concomitantly dietary supplements containing soy isoflavones in combination to treat their post-menopausal symptoms. The aim of this study was
Autor:
Yves Henrotin, Stefano Persiani, Patrik Önnerfjord, Elena Losina, L.S. Lohmander, Martin Englund, Virginia B. Kraus, Francisco J. Blanco
Publikováno v:
Kraus, V B, Blanco, F J, Englund, M, Henrotin, Y, Lohmander, L S, Losina, E, Önnerfjord, P & Persiani, S 2015, ' OARSI Clinical Trials Recommendations : Soluble biomarker assessments in clinical trials in osteoarthritis ', Osteoarthritis and Cartilage, vol. 23, no. 5, pp. 686-697 . https://doi.org/10.1016/j.joca.2015.03.002
The objective of this work was to describe requirements for inclusion of soluble biomarkers in osteoarthritis (OA) clinical trials and progress toward OA-related biomarker qualification. The Guidelines for Biomarkers Working Group, representing exper
Publikováno v:
Journal of Chromatography B. :1-9
To investigate the pharmacokinetics of silibinin and silibinin hemisuccinate in human plasma, two high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) methods were developed and validated. The methods require a small volum
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease. 4:167-180
Glucosamine is an amino monosaccharide and a natural constituent of glycosaminoglycans in articular cartilage. When administered exogenously, it is used for the treatment of osteoarthritis as a prescription drug or a dietary supplement. The latter us
Autor:
Carolina Colliva, Aldo Roda, Lorenzo Zaccarelli, Stefano Persiani, Elisabetta Pastorini, Stefania Vecchiotti, Lucio C. Rovati, Roberto Rotini, Giulia Roatti
Publikováno v:
Analytica Chimica Acta. 695:77-83
A new HPLC-ESI-MS/MS method for the determination of glucosamine (2-amino-2-deoxy-d-glucose) in rabbit cartilage was developed and optimized. Glucosamine was extracted from cartilage by cryogenic grinding followed by protein precipitation with trichl
Autor:
Roberto Luksch, Maria Grazia Villani, Franca Formelli, Elena Cavadini, Stefano Persiani, Alberto Garaventa, Valentina Appierto
Publikováno v:
Cancer Chemotherapy and Pharmacology. 62:655-665
Pharmacokinetic data on fenretinide (4-HPR) are scant, thus limiting the rational use of the drug. We investigated the pharmacokinetics of 4-HPR and its active metabolite 4-oxo-fenretinide (4-oxo-4-HPR).Pharmacokinetics were assessed in 18 children (
Autor:
Stefano Persiani, Patrice Larger
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 2:675-686
Translational medicine is the drug development phase in which preclinical and clinical applied research is conducted to aid dose and disease selection with great financial impact. Thus, during this phase, early discontinuation of a drug that will lat
Autor:
Partha Roy, Stefano Persiani, Abhijeet Jakate, Massimo D'Amato, Ram Kapil, Julie Wangsa, Lucio C. Rovati
Publikováno v:
Clinical Pharmacokinetics. 45:1177-1188
Dexloxiglumide is a potent and selective cholecystokinin type 1 (CCK1) receptor antagonist currently under development in a variety of diseases affecting the gastrointestinal tract such as gastro-oesophageal reflux disease, irritable bowel syndrome (